Bicycle Therapeutics PLC
BCYC- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001761612
No open-market purchases or sales by Bicycle Therapeutics PLC insiders were filed in the last 90 days; 103 institutions reported holding it in 13F filings for Q2 2026, worth $157.9M in total; no superinvestor holds it.
Q2 2023 vs. Q1 2023
How the institutions holding Bicycle Therapeutics PLC changed between Q1 2023 and Q2 2023.
All holders in Q2 2023All holders in Q1 2023
| Measure | Q1 2023 | Q2 2023 | Change |
|---|---|---|---|
| Holders | 89 | 85 | −4 |
| Shares | 23.6M | 24.3M | +697.8K (+3.0%) |
| Value | $498.9M | $618.5M | +$119.6M (+24.0%) |
New holders (8)
Institutions that held Bicycle Therapeutics PLC at the end of Q2 2023 but not at the end of Q1 2023.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Nomura Holdings Inc | 400,000 | $10.2M | 0.10% |
| Kennedy Capital Management, Inc. | 123,188 | $3.14M | 0.07% |
| State Street Corp | 8,666 | $221.2K | 0.00% |
| Exchange Traded Concepts, LLC | 5,276 | $134.6K | 0.00% |
| BIT Capital GmbH | 4,850 | $123.8K | 0.01% |
| Rhumbline Advisers | 380 | $9.70K | 0.00% |
| Raleigh Capital Management Inc. | 185 | $4.72K | 0.00% |
| Bell Investment Advisors, Inc | 37 | $945 | 0.00% |
Sold out (12)
Institutions that held Bicycle Therapeutics PLC at the end of Q1 2023 and filed for Q2 2023 without it.
| Institution | Shares, Q1 2023 | Value, Q1 2023 |
|---|---|---|
| J. Goldman & Co LP | 49,944 | $1.06M |
| Caption Management, LLC | 26,000 | $553.0K |
| Vident Investment Advisory, LLC | 24,287 | $516.6K |
| Eagle Health Investments LP | 23,500 | $499.8K |
| Jane Street Group, LLC | 9,800 | $208.4K |
| Values First Advisors, Inc. | 2,392 | $50.9K |
| Aquatic Capital Management LLC | 800 | $17.0K |
| Quantbot Technologies LP | 300 | $6.38K |
| Advisory Services Network, LLC | 115 | $2.45K |
| Crewe Advisors LLC | 83 | $1.77K |
| Wells Fargo & Company | 19 | $404 |
| Parallel Advisors, LLC | 5 | $106 |